![]() Abeona Therapeutics Abeona Therapeutics is focusing on developing innovative therapies, including gene therapies, for rare diseases, including Sanfilippo Syndrome. | ||
Founding Date | Founding Date 2013 | Founding Date 1909 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Dallas, US HQ Madrid, ES Cleveland, US New York, US | Locations Sant Cugat del Vallès, ES HQ Buenos Aires, AR Clayton South, AU São Paulo, BR Mississauga, CA Las Condes, CL see more |
Employees | Employees 5737% decrease | Employees 23,800 |
Valuation ($) | Valuation ($) 284.6 m | Valuation ($) 6.7 b |
Financial | ||
Revenue (est.) | Revenue (est.) $5.8m (FY, 2025) | Revenue (est.) €7.5b (FY, 2025) |
Cost of goods | Cost of goods $1.5m (FY, 2025) | Cost of goods €4.2b (FY, 2025) |
Gross profit | Gross profit $4.3m (FY, 2025) | Gross profit €3.3b (FY, 2025) |
Net income | Net income $71.2m (FY, 2025) | Net income €500m (FY, 2025) |

Grifols is a pharmaceutical and chemical manufacturer.
View company